Egypt Cancer Diagnostic Market is anticipated to witness
a growth of steady CAGR during the forecast period, 2024-2028. This
can be ascribed to the rising prevalence of various chronic diseases such as
cancer, cardiovascular diseases, diabetes, and others, growing number of
private diagnostic centres, increasing lifestyle diseases, increasing rate of rejuvenation and anti-aging amongst
population. Egypt ranks number 2 in the world in terms
of deaths caused by cancer, especially liver cancer. According to Global Cancer
Observatory (Egypt), in 2020, around 134,632 new cancer cases were reported in
the country, in which the males and females accounted for 66,542 and 68,090 cases
respectively in 2020.
Cancer diagnostics is a method of
identifying different biomarkers, proteins, and some signs that lead to the
identification of the presence of a cancerous tumor. Efficient diagnostic
testing is used to validate or rule out the existence of illness, monitor the
progression of the disease, and schedule & review treatment outcomes.
Diagnostic procedures for cancer may include imaging, tumor biopsy, laboratory
tests (including tests for tumor markers), endoscopic examination, surgery, or
genetic testing. However, the demand for new diagnostic techniques/tools is
increasing which is further expected to drive the growth of Cancer Diagnostic
Market.
The growing prevalence of new cancer
cases, rising awareness for cancer screening, the advanced technological
advancement with highest accuracy and precision, and the growing awareness for
early detection of cancer amongst population globally are projected to propel
the growth of market. Additionally, expansion in research & development schemes
being initiated by various governments institutions, private institutions and diagnostic
imaging centres across the globe is further expected to create lucrative
opportunities for the growth of Cancer Diagnostic Market in the coming years.
According to the latest report of World Health Organization, in 2020, liver
cancer deaths in Egypt accounted for 24,512 or 4.57% of total deaths.
Growing
number of private diagnostic centres
The number of private
diagnostic centers are increasing across the country owing to the rising demand
of diagnostic imaging procedures as well as growing burden on public hospitals
due to their limited number of imaging modalities. According to the recent
developments, in 2021, a company namely Fujifilm DKH LLP in joint venture with Dr.
Kutty's Healthcare had opened hospitals and screening centres in the Middle
East. Due to these centres, cancer can be diagnosed at early-stage and can
be treated easily, and patients can recover smoothly.
Rising
Rejuvenation and Early-aging in Population
In Egypt, currently, 74%
(~75 million) of the population is under the age of 40 years and it is expected
to increase to 86 million by 2030. Concurrently, only 8% (~7.7 million) of the
population is over the age of 60 years, which is expected to increase to 13.8%
(~18 million) by the end of 2030. However, 4.6 million of the population is
above the age of 65 years which is expected to increase to 12.3 million by 2030.
Therefore, there is an increasing demand for services focusing on rejuvenation
and anti-aging including stem cells therapy, hyperbaric oxygen therapy (HBOT)
and other similar services.
Sedative
Lifestyle Leads to Cancer
Cancer is caused due to the
unhealthy lifestyle. Sedentary behaviors have wide-ranging adverse
impacts on the human body including increased all-cause mortality,
cardiovascular disease mortality, cancer risk, and risks of metabolic disorders
such as diabetes mellitus, hypertension, and dyslipidemia; musculoskeletal
disorders such as arthralgia and osteoporosis, depression, etc. For
instance, Egypt has one of the highest prevalence of lifestyle diseases in the
world with approximately 17% of population over 20 years with diabetes, 32%
with obesity and over 25% suffering from hypertension. According to Centers
for Disease Control and Prevention (CDC), around 15% adults are physically
inactive, do not participate in activities such as running, walking for
exercise, or gardening. Therefore, sedentary lifestyle and lack of physical
activity can lead to cancer and thereby
propel the growth of Egypt Cancer Diagnostic Market.
Growth in Research &
Development
Rapid advancements in
research and development (R&D) practices and activities are driving the
growth of the market on account of growing need of developing novel diagnostic
solutions for the treatment of different life-threatening diseases. According to World Data Atlas (Egypt), in 2020, R&D
expenditure for Egypt was 1 %. Therefore, the R&D expenditure of Egypt
increased from 0.2 % in 1998 to 1 % in 2020 growing at an average annual rate
of 9.82%. A recent advancement also includes the cancer treatment with
immunotherapy that is anticipated to be significant to high availability of
immunotherapy drugs, and several initiatives are taken by the government and
non-government organizations for making diagnostic procedures affordable. This
in turn, supports the growth of Egypt Cancer Diagnostic Market.
Download Free Sample Report
Market Segmentation
Egypt Cancer Diagnostic Market can
be segmented on the basis of product, technology, application,
end user, region, and company. Based on product, the market can be further segmented
into consumable, and instruments. Based on technology, the market is further
split into IVD testing, imaging, and biopsy. Based on application, the market
is further divided into breast cancer, lung cancer, colorectal cancer, and others.
Based on end user, the market is further segmented into hospitals &
clinics, diagnostic laboratories, and others.
Company Profiles
Abbott Egypt, Agilent Egypt, Roche
Egypt LLC, FUJIFILM Healthcare Middle East S.A.E., Siemens Healthineers Egypt, BioMerieux
Egypt, GE Healthcare Egypt, Ortho Clinical Diagnostics, PerkinElmer
International C.V., and Epigenomics Egypt etc. are some of the key players
operating in the Egypt Cancer Diagnostic market.
|
Attribute
|
Details
|
|
Base Year
|
2022
|
|
Historic Data
|
2018 –
2021
|
|
Estimated Year
|
2023
|
|
Forecast Period
|
2024
– 2028
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
|
|
Report coverage
|
Revenue forecast, company share, competitive landscape, growth
factors, and trends
|
|
Segments covered
|
Product
Technology
Application
End User
Region
Company
|
|
Regional scope
|
Cairo, Qalyubia, Alexandria, Port Said, Giza, Suez, Rest of
Egypt
|
|
Key companies profiled
|
Abbott Egypt, Agilent Egypt, Roche Egypt LLC, FUJIFILM
Healthcare Middle East S.A.E., Siemens Healthineers Egypt, BioMerieux Egypt,
GE Healthcare Egypt, Ortho Clinical Diagnostics, PerkinElmer International
C.V., Epigenomics Egypt
|
|
Customization scope
|
10% free report customization with purchase. Addition or
alteration to country, regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can also
provide the editable version of the report in PPT/Word format on special
request)
|
Report Scope:
In this report, Egypt Cancer Diagnostic
Market has been segmented into following categories, in addition to the
industry trends which have also been detailed below:
- Cancer Diagnostic Market, By Product:
- Cancer Diagnostic Market, By Technology
- IVD Testing
- Imaging
- Biopsy
- Cancer Diagnostic Market, By Application:
o
Breast
Cancer
o
Lung
Cancer
o
Colorectal
Cancer
o
Others
- Cancer Diagnostic Market, By Region:
- Cairo
- Qalyubia
- Alexandria
- Port Said
- Giza
- Suez
- Rest of
Egypt
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in Egypt Cancer Diagnostic Market.
Available Customizations:
With the given market data, TechSci Research offers customizations
according to a company’s specific needs. The following customization options
are available for the report:
Company
Information:
- Detailed analysis and profiling of additional market players (up to five).
Egypt Cancer Diagnostic Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]